West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 89/100

West Pharmaceutical Services Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 01:30PM GMT
Release Date Price: R$47.5
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. Thank you for joining us. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. With me, I have the pleasure of Eric Green, CEO, Chair of the Board and President of West Pharmaceuticals and you guys have a (inaudible).

Eric M. Green
West Pharmaceutical Services, Inc. - Chair, President & CEO

(inaudible). I appreciate the invitation here to the Barclays Healthcare Conference. (inaudible) for the great list of one-on-ones today.

Great. Before we get started, I wanted (inaudible) you can find it on the deck posted on our website and I will post them here on the screen.

Let's start about West. And April 14, it's a pretty major milestone for us at West. It will be 100 years of our existence. And it's been true to reform around supporting patients across the globe. when you think about the level of innovation, global expansion and where we are today in this whole process in the last 100 years. What gets us excited at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot